J H Stone

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi request reprint Immune-mediated inner ear disease
    J H Stone
    Division of Rheumatology, Johns Hopkins Vasculitis Center, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Curr Opin Rheumatol 12:32-40. 2000
  2. ncbi request reprint "Essential" cutaneous vasculitis: what every rheumatologist should know about vasculitis of the skin
    J H Stone
    Division of Rheumatology Department of Medicine, The Johns Hopkins Vasculitis Center, Johns Hopkins University, Baltimore, Maryland 21205, USA
    Curr Opin Rheumatol 13:23-34. 2001
  3. ncbi request reprint Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety
    J H Stone
    Johns Hopkins University, Baltimore, Maryland, USA
    Arthritis Rheum 44:1149-54. 2001
  4. ncbi request reprint Annular leukocytoclastic vasculitis associated with monoclonal gammopathy of unknown significance
    H C Nousari
    Department of Dermatology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    J Am Acad Dermatol 43:955-7. 2000
  5. ncbi request reprint A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS)
    J H Stone
    Johns Hopkins University, Baltimore, Maryland, USA
    Arthritis Rheum 44:912-20. 2001
  6. ncbi request reprint Reliability of normal findings on MR imaging for excluding the diagnosis of vasculitis of the central nervous system
    B A Wasserman
    Department of Radiology, Neuroradiology Division, The Johns Hopkins University School of Medicine, The Johns Hopkins Hospital, Phipps B-108, 600 N. Wolfe St, Baltimore, MD 21287-2182, USA
    AJR Am J Roentgenol 177:455-9. 2001
  7. ncbi request reprint New approaches to treatment in systemic vasculitis: biological therapies
    S M Levine
    Division of Rheumatology and Department of Medicine, The Johns Hopkins Vasculitis Center, Baltimore, MD 21205, USA
    Best Pract Res Clin Rheumatol 15:315-33. 2001
  8. ncbi request reprint Vasculitis. A collection of pearls and myths
    J H Stone
    Department of Medicine, Johns Hopkins University School of Medicine, Johns Hopkins Vasculitis Center, Baltimore, Maryland, USA
    Rheum Dis Clin North Am 27:677-728, v. 2001
  9. ncbi request reprint Treatment of Wegener's granulomatosis
    M J Regan
    Department of Medicine, Johns Hopkins University School of Medicine, Johns Hopkins Bayview Medical Center, Baltimore, Maryland, USA
    Rheum Dis Clin North Am 27:863-86, viii. 2001

Collaborators

Detail Information

Publications9

  1. ncbi request reprint Immune-mediated inner ear disease
    J H Stone
    Division of Rheumatology, Johns Hopkins Vasculitis Center, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Curr Opin Rheumatol 12:32-40. 2000
    ..However, if treated promptly with aggressive immunosuppression, the devastating sequelae of IMIED may be avoided. In this article, we review the pathophysiology, clinical evaluation, diagnostic testing, and therapy of IMIED...
  2. ncbi request reprint "Essential" cutaneous vasculitis: what every rheumatologist should know about vasculitis of the skin
    J H Stone
    Division of Rheumatology Department of Medicine, The Johns Hopkins Vasculitis Center, Johns Hopkins University, Baltimore, Maryland 21205, USA
    Curr Opin Rheumatol 13:23-34. 2001
    ..In this review, we discuss a classification scheme for the cutaneous vasculitides, outline the work-up for evaluating patients with these disorders, and describe the essential features of the major categories of skin vasculitis...
  3. ncbi request reprint Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety
    J H Stone
    Johns Hopkins University, Baltimore, Maryland, USA
    Arthritis Rheum 44:1149-54. 2001
    ..Adverse events were few. BVAS/WG scores improved at 6 months, but intermittently active WG (occasionally severe) was common. A randomized, double-masked trial to assess the efficacy of etanercept in WG has begun...
  4. ncbi request reprint Annular leukocytoclastic vasculitis associated with monoclonal gammopathy of unknown significance
    H C Nousari
    Department of Dermatology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    J Am Acad Dermatol 43:955-7. 2000
    ..The rare association between monoclonal gammopathy of unknown significance and leukocytoclastic vasculitis as well as the unusual annular presentation of the disease in this patient is discussed, and the relevant literature is reviewed...
  5. ncbi request reprint A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS)
    J H Stone
    Johns Hopkins University, Baltimore, Maryland, USA
    Arthritis Rheum 44:912-20. 2001
    ..The INSSYS will use the BVAS/WG to assess the primary outcome in a phase II/III trial of etanercept in WG...
  6. ncbi request reprint Reliability of normal findings on MR imaging for excluding the diagnosis of vasculitis of the central nervous system
    B A Wasserman
    Department of Radiology, Neuroradiology Division, The Johns Hopkins University School of Medicine, The Johns Hopkins Hospital, Phipps B-108, 600 N. Wolfe St, Baltimore, MD 21287-2182, USA
    AJR Am J Roentgenol 177:455-9. 2001
    ....
  7. ncbi request reprint New approaches to treatment in systemic vasculitis: biological therapies
    S M Levine
    Division of Rheumatology and Department of Medicine, The Johns Hopkins Vasculitis Center, Baltimore, MD 21205, USA
    Best Pract Res Clin Rheumatol 15:315-33. 2001
    ..The potential biological targets discussed include cytokines such as tumour necrosis factor; interleukins-1, -6, and -12; interferon-gamma; the co-stimulatory molecules B7-1 and B7-2; and others...
  8. ncbi request reprint Vasculitis. A collection of pearls and myths
    J H Stone
    Department of Medicine, Johns Hopkins University School of Medicine, Johns Hopkins Vasculitis Center, Baltimore, Maryland, USA
    Rheum Dis Clin North Am 27:677-728, v. 2001
    ..Over time, numerous myths and an occasional pearl have arisen from the care of patients with these disorders. In this collection of pearls and myths, we have attempted to pool our knowledge about the clinical care of vasculitis patients...
  9. ncbi request reprint Treatment of Wegener's granulomatosis
    M J Regan
    Department of Medicine, Johns Hopkins University School of Medicine, Johns Hopkins Bayview Medical Center, Baltimore, Maryland, USA
    Rheum Dis Clin North Am 27:863-86, viii. 2001
    ..e., those designed to induce remissions and those intended to maintain them) is useful in the formulation of current disease management strategies and in the investigation of new therapies for WG...